Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback.
Busch
M P
MP
Blood Centers of the Pacific, Irwin Center, San Francisco, CA 94118, USA. mpbusch@itsa.ucsf.edu
Tobler
L H
LH
Tegtmeier
G
G
Polito
A
A
Quan
S
S
Hirschler
N V
NV
Dockter
J
J
Giachetti
C
C
Mimms
L
L
D001782:Blood Donors; D016174:Hepacivirus / Q000276:immunology*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D015151:Immunoblotting / Q000379:methods*; D007124:Immunoenzyme Techniques; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins
D018937:Hepatitis C Antibodies; D011994:Recombinant Proteins